Sample Business Hotel

Japanese

Disease due to aging and treatment of pioneer "Bill Andrews, Ph.D."

profile

Bill Andrews, Ph.D. has worked in the biotech industry for more than 30 years, focusing the last 18 years on finding ways to extend human lifespan through the intervention of telomere shortening in human cells. Bill Andrews, Ph.D. earned his Ph.D. in Molecular and Population Genetics at the University of Georgia in 1981. He was a Senior Scientist at Armos Corporation and Codon Corporation, Director of Molecular Biology at Codon and at Geron Corporation, and Director of Technology Development at EOS Biosciences. While Director of Molecular Biology at Geron Corporation from 1992 to 1997, Bill Andrews, Ph.D. was one of the principal discoverers of both the RNA and protein components of human telomerase and was awarded 2nd place as "National Inventor of the Year" in 1997 for this work. He is presently a named inventor on 43 US issued telomerase patents.

↑Page top

U.S.-Issued Patents

  • DNA encoding an antigenic protein derived from Eimeriatenellaand vaccines for prevention of coccidiosis caused by Eimeriatenella
      Patent Number: US4874705, Issued 1989-10-17
  • DNA encoding an antigenic protein derived from Eimeriatenellaand vaccines for prevention of coccidiosis caused by Eimeriatenella
      Patent Number: US5187080, Issued 1993-02-16
  • Mammalian telomerase
      Patent Number: US5583016, Issued 1996-12-10
  • Mutagenesis methods and compositions
      Patent Number: US5702931, Issued 1997-12-30
  • Assays for the DNA component of human telomerase
      Patent Number: US5776679, Issued 1998-07-07
  • Protease-resistant thrombomodulinanalogs
      Patent Number: US5827824, Issued 1998-10-27
  • Mammalian telomerase
      Patent Number: US5837857, Issued 1998-11-17
  • Methods and reagents for regulating telomere length and telomerase activity
      Patent Number: US5858777, Issued 1999-01-12
  • Protease-resistant thrombomodulinanalogs
      Patent Number: US5863760, Issued 1999-01-26
  • RNA component of mouse, rat, Chinese hamster and bovine telomerase
      Patent Number: US5876979, Issued 1999-03-02
  • Mammalian telomerase
      Patent Number: US5958680, Issued 1999-09-28
  • RNA component of telomerase
      Patent Number: US6013468, Issued 2000-01-11
  • Mammalian telomerase RNA gene promoter
      Patent Number: US6054575, Issued 2000-04-25
  • Protease-resistant thrombomodulinanalogs
      Patent Number: US6063763, Issued 2000-05-16
  • Mammalian telomerase
      Patent Number: US6258535, Issued 2001-07-10
  • Telomerase
      Patent Number: US6261836, Issued 2001-07-17
  • Peptides related to TPC2 and TPC3, two proteins that are coexpressedwith telomerase activity
      Patent Number: US6300110, Issued 2001-10-09
  • Mammalian telomerase
      Patent Number: US6320039, Issued 2001-11-20
  • Antisense compositions for detecting and inhibiting telomerase reverse transcriptase
      Patent Number: US6444650, Issued 2002-09-03
  • Human telomerase catalytic subunit: diagnostic and therapeutic methods
      Patent Number: US6475789, Issued 2002-11-05
  • Mammalian telomerase
      Patent Number: US6548298, Issued 2003-04-15
  • Promoter for telomerase reverse transcriptase
      Patent Number: US6610839, Issued 2003-08-26
  • Cells immortalized with telomerase reverse transcriptase for use in drug screening
      Patent Number: US6617110, Issued 2003-09-09
  • Antisense compositions for detecting and inhibiting telomerase reverse transcriptase
      Patent Number: US6627619, Issued 2003-09-30
  • Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression
      Patent Number: US6686159, Issued 2004-02-03
  • Telomerase promoter driving expression of therapeutic gene sequences
      Patent Number: US6777203, Issued 2004-08-17
  • Method for detecting polynucleotides encoding telomerase
      Patent Number: US6808880, Issued 2004-10-26
  • Telomerase
      Patent Number: US6921664, Issued 2005-07-26
  • Genes for human telomerase reverse transcriptase and telomerase variants
      Patent Number: US6927285, Issued 2005-08-09
  • Methods for detecting nucleic acids encoding human telomerase reverse transcriptase
      Patent Number: US7005262, Issued 2006-02-28
  • Telomerase
      Patent Number: US7056513, Issued 2006-06-06
  • Mammalian cells that have increased proliferative capacity
      Patent Number: US7195911, Issued 2007-03-27
  • Regulatory segments of the human gene for telomerase reverse transcriptase
      Patent Number: US7199234, Issued 2007-04-03
  • Telomerase expression repressor proteins and methods of using the same
      Patent Number: US7211435, Issued 2007-05-01
  • Assays for TERT promoter modulatory agents using a telomerase structural RNA component
      Patent Number: US7226744, Issued 2007-06-05
  • Nucleic acids encoding human telomerase reverse transcriptase and related homologs
      Patent Number: US7262288, Issued 2007-08-28
  • Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression
      Patent Number: US7279328, Issued 2007-10-09
  • Antibody to telomerase reverse transcriptase
      Patent Number: US7285639, Issued 2007-10-23
  • Identifying and testing antisense oligonucleotides that inhibit telomerase reverse transcriptase
      Patent Number: US7297488, Issued 2007-11-20
  • Telomerase promoters sequences for screening telomerase modulators
      Patent Number: US7378244, Issued 2008-05-27
  • Treating cancer using a telomerase vaccine
      Patent Number: US7413864, Issued 2008-08-19
  • Muteinsof human telomerase reverse transcriptase lacking telomerase catalytic activity
      Patent Number: US7517971, Issued 2009-04-14
  • Nucleic acid compositions for eliciting an immune response against telomerase reverse transcriptase
      Patent Number: US7560437, Issued 2009-07-14
  • Increasing the proliferative capacity of cells using telomerase reverse transcriptase
      Patent Number: US7585622, Issued 2009-09-08
  • Human telomerase reverse transcriptase polypeptides
      Patent Number: US7622549, Issued 2009-11-24
  • Antibody to telomerase reverse transcriptive
      Patent Number: US7750121, Issued 2010-07-06
  • Telomerase expression repressor proteins and methods of using the same
      Patent Number: US7795416, Issued 2010-09-14
  • Regulatory segments of the human gene for telomerase reverse transcriptase
      Patent Number: US7879609, Issued 2011-02-01
  • Kit for detection of telomerase reverse transcriptase nucleic acids
      Patent Number: US8222392, Issued 2012-07-17
  • Human telomerase catalytic subunit
      Patent Number: US8236774, Issued 2012-08-07

↑Page top

The video of Bill Andrews, Ph.D.

❖lecture in "INDIA TODAY GROUP"  (India)Mar 2016 >>View
❖India Today Conclave 2016:Live  (India)Feb 2016 >>View
❖"Health program 02 of the Korean state-run KBS " (Korea)Feb 2016 >>View
❖"Health program 01 of the Korean state-run KBS " (Korea)Feb 2016 >>View
❖After broadcast of NZ, "South Korea MBC special program" (Korea)Nov 2015 >>View
❖Bill Andrews, Ph.D. interview in "ONE News Now." (NZ)Jul 201 >>View
❖Documentary film of the "the IMMORTALISTS" (preview) Bill Andrews, Ph.D.2014 published >>View
❖Telomerase effect in the mouse experiment(ABC News)2010 broadcast >>View
❖Telomerase induction active substance "TA-65"(Video Clip)In 2007 >>View

↑ PAGE TOP